Dravet syndrome therapy (NeuCyte)

N/A

Report date: 2025/03/18 18:21:39
NME

Base Information

Drug NameDravet syndrome therapy (NeuCyte)
Drug Alias NameDravet syndrome therapy (Trillium)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsEpilepsies, Myoclonic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTrillium Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeucyte Inc
Inactive CompaniesTrillium Therapeutics Inc
Active IndicationsEpilepsies, Myoclonic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A